Published on Wednesday August 01, 2018

Our company has started working on new projects:

  • Smooth Drug Development starts working on documentation for a phase three study in fatty degeneration of liver for a Russian company.
  • Our company prepares for an observational program of cosmetics in patients with atopy for a European company.
  • Smooth Drug Development was awarded a bioequivalence trial of (INN: Etoricoxib) for an international pharmaceutical company.
  • Our company was awarded with an observational study in hemorrhoid, held by one of the major players on the international pharmaceutical market.